Signs and SymptomsSD patients often present with the complaint of word-finding difficulties. Clinical signs include fluent aphasia, anomia, impaired comprehension of word meaning, and visual associative agnosia (inability to match semantically-related pictures or objects). As the disease progresses, behavioural and personality changes are often seen similar to those seen in frontotemporal dementia although cases have been described of 'pure' semantic dementia with few late behavioural symptoms. NeuropsychologyPatients perform poorly on tests of semantic knowledge. Published tests include both verbal and non-verbal tasks e.g. The Warrington concrete and abstract word synonym test (Warrington EK, McKenna P, Orpwood L. Single word comprehension: a concrete and abstract word synonym test. Neuropsychological Rehabilitation 1998; 8: 143-154.) and The Pyramids and Palm Trees task (Howard and Patterson, 1992) Testing will also reveal deficits in picture naming (with semantic errors being made e.g. "dog" for a picture of a hippopotamus) and decreased category fluency. ImagingStructural MRI imaging shows a characteristic pattern of atrophy in the temporal lobes (predominantly on the left) with inferior greater than superior involvement and anterior temporal lobe atrophy greater than posterior. This distinguishes it from Alzheimer's disease (Chan et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol. 2001 Apr;49(4):433-42). PathologyThe majority of patients with SD will have ubiquitin-positive, tau-negative inclusions although like all of the FTLD syndromes other pathologies have been described including Pick's disease and other tau positive pathology (Davies RR et al. The pathological basis of semantic dementia. Brain. 2005 Sep;128(Pt 9):1984-95.) With regard to the ubiquitin-positive cases, it is generally thought that these represent TDP-43 protein accumulations resulting from mutation in the progranulin gene. GeneticsOf all the FTLD syndromes SD is least likely to run in families and is usually sporadic (Goldman JS et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005 Dec 13;65(11):1817-9.) ManagementThere is currently no known curative treatment for this condition. Supportive care is essential in what is a greatly debilitating problem. External links
References
See also
| |